by Truveta Research | Nov 9, 2025 | Research, Research Insights
Authors: Katherine Brown, PhD, MSN, RN ⊕Truveta, Inc, Bellevue, WA, Sarah Platt, MS ⊕Truveta, Inc, Bellevue, WA, Agnes Pastwa ⊕Truveta, Inc, Bellevue, WA, Sunny Guin, PhD ⊕Truveta, Inc, Bellevue, WA, Emily Webber, PhD ⊕Truveta, Inc, Bellevue, WA Advanced natural...
by Truveta staff | Oct 29, 2025 | Research
Body composition is a critical factor in understanding health risk, yet it is rarely measured in routine clinical care. Instead, clinicians and researchers often rely on BMI — a measure that misses the nuance of fat distribution and its impact on outcomes like...
by Truveta Research | Oct 24, 2025 | Featured post, Research, Research Insights
Respiratory virus–associated hospitalizations declined overall in September 2025 (–27.1%). COVID-associated hospitalizations declined substantially (-45.1%) but still account for the most virus-associated hospitalizations in those aged 65 and older (1.1%). Rhinovirus...
by Truveta Research | Oct 21, 2025 | Featured research, Research, Research Insights
In patients with CKD and diabetes, anemia prevalence and severity increased from stage 1 to stage 5, with overall anemia rising from 46.4% to 85.0% and severe anemia from 2.5% to 11.8% Erythropoiesis-stimulating agents (ESAs) and IV iron use rose as hemoglobin levels...
by Truveta Research | Oct 20, 2025 | Featured research, Research, Research Insights
Overall GLP-1 prescribing rates (GLP-1 RA prescriptions per total prescriptions) in September 2025 remained stable relative to June 2025 (+4.6%). As of September 2025, GLP-1 prescriptions account for 6.5 out of every 100 prescriptions in the US. Tirzepatide continues...
by Truveta Research | Oct 17, 2025 | Research, Research Insights
Nearly half of patients with gestational diabetes mellitus (GDM) received nutrition counseling within 45 days of diagnosis, while smaller proportions initiated insulin (15%) or metformin (10%). Despite being the first-line intervention, about half of patients with GDM...
